{Reference Type}: Journal Article
{Title}: Case fatality of COVID-19 in patients with neurodegenerative dementia.
{Author}: Reyes-Bueno JA;Mena-Vázquez N;Ojea-Ortega T;Gonzalez-Sotomayor MM;Cabezudo-Garcia P;Ciano-Petersen NL;Pons-Pons G;Castro-Sánchez MV;Serrano-Castro PJ;
{Journal}: Neurologia (Engl Ed)
{Volume}: 35
{Issue}: 9
{Year}: Nov 2020 0
暂无{DOI}: 10.1016/j.nrl.2020.07.005
{Abstract}: BACKGROUND: The elderly population is the group most threatened by COVID-19, with the highest mortality rates. This study aims to analyse the case fatality of COVID-19 in a cohort of patients with degenerative dementia.
METHODS: We conducted a descriptive case-control study of a sample of patients diagnosed with primary neurodegenerative dementia.
RESULTS: Twenty-four of the 88 patients with COVID-19 included in the study died: 10/23 (43.4%) patients diagnosed with dementia and 14/65 (21.5%) controls; this difference was statistically significant.
CONCLUSIONS: Our results suggest that case fatality of COVID-19 is significantly higher among patients with primary degenerative dementia than in other patients with similar mean ages and comorbidities.